In this edition: Democratic governors have set up a shadow public-health alliance, big changes are coming to Medicare this year and hospitals are partnering with high schools to train more healthcare workers.

Blue states are setting up a shadow public-health alliance. Fifteen Democratic governors are forming a group to detect and respond to disease threats, saying federal cuts and policy changes are putting their citizens at risk.

Autism cases have risen as the diagnosis itself has shifted. Though there’s debate about why childhood autism diagnoses have surged, many doctors and scientists point to evolving clinical criteria that have expanded the definition of the disorder.

Big changes are coming for 2026 Medicare plans. Skinnier benefits, higher premiums and fewer options mean more than a million seniors should shop for new coverage during open enrollment. Here’s what else you need to know.

It’s never too late to quit drinking alcohol, writes Bob Brody. In an essay for the Journal, the author describes the physical and mental rewards of alcohol abstinence that can come after decades of drinking, even for people in their 70s and older.

Pregnant women told WSJ how they feel about taking Tylenol after President Trump warned against it, contradicting medical associations and many scientists. These women said they are now balancing health advice, politics and personal experience.

To find workers, hospitals are training teenagers. As health systems nationwide confront a worker shortage, some have begun to partner with local high schools to create employee pipelines.

Hims & Hers is now providing menopause care, expanding its hormone-replacement therapy offerings. The telehealth company sees the new offering as a major opportunity, given about 1.3 million women in the U.S. experience menopause each year.

AstraZeneca struck a deal with the Trump administration on lowering the prices of its drugs, some of which will be available for purchase through a government website next year. The agreement follows a similar deal that Pfizer struck last week.

This newsletter was compiled by WSJ’s newsletters team. Email us by replying to this newsletter. Got a tip for us? Here's how to submit.